The 2026 AI power shift The industry moves from task copilots to integrated discovery systems.

https://www.drugdiscoverynews.com/the-2026-ai-power-shift-17020?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9sAIBVW9AMuAjk71Igb6h4LpHYKHIsUKjuUbN_Uc7OHGLluczU6wJN-10AXAVqslgROd0sEgamcfvhiIMjjD5mOi3xZg&_hsmi=413196489&utm_content=413196489&utm_source=hs_email The biotechnology industry is moving past the initial excitement of artificial intelligence (AI) to confront a more complex reality: the transition from isolated digital tools to fully integrated, AI-native discovery systems.